FORNARO, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 397
NA - Nord America 306
AS - Asia 94
AF - Africa 1
Totale 798
Nazione #
US - Stati Uniti d'America 305
RU - Federazione Russa 142
PL - Polonia 128
IT - Italia 39
IE - Irlanda 35
SG - Singapore 28
SE - Svezia 27
CN - Cina 22
HK - Hong Kong 14
JO - Giordania 12
IN - India 11
DK - Danimarca 7
DE - Germania 5
GB - Regno Unito 5
VN - Vietnam 4
CH - Svizzera 2
ES - Italia 2
GR - Grecia 2
KR - Corea 2
UA - Ucraina 2
CA - Canada 1
CI - Costa d'Avorio 1
JP - Giappone 1
NL - Olanda 1
Totale 798
Città #
Warsaw 128
Fairfield 48
Dublin 35
Ashburn 29
Seattle 28
Chandler 27
Woodbridge 22
Singapore 21
Cambridge 20
Houston 18
Wilmington 17
Lawrence 12
Altamura 10
Florence 10
Hong Kong 8
Copenhagen 7
Princeton 7
Shanghai 7
Boston 6
Mumbai 6
New York 6
Beijing 5
Moscow 5
New Delhi 5
Ann Arbor 4
Buffalo 4
Changsha 4
Medford 4
Nanjing 4
Norwalk 4
San Diego 4
Boardman 3
Munich 3
Andover 2
Barcelona 2
Bern 2
Chiswick 2
Dong Ket 2
Falls Church 2
Los Angeles 2
Menlo Park 2
Milan 2
Molfetta 2
Prato 2
Vicenza 2
Abidjan 1
Amsterdam 1
Centro 1
Genova 1
Hackney 1
Leawood 1
North Bergen 1
Phoenix 1
Pontedera 1
Portland 1
Prescot 1
Rome 1
San Miniato Basso 1
Santa Clara 1
Seoul 1
Toronto 1
Wandsworth 1
Totale 562
Nome #
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 227
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 121
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 93
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology 91
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 88
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 58
Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure 53
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 42
Eligibility for vericiguat in a real-world, contemporary heart failure population 20
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 15
Totale 808
Categoria #
all - tutte 3.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.029


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 10 9 8 20 16 14 12 20 1
2020/2021129 12 8 7 13 4 6 6 7 7 48 7 4
2021/202275 8 0 6 2 0 4 6 4 2 7 11 25
2022/2023144 9 33 11 4 4 25 19 11 20 2 4 2
2023/202479 2 5 6 5 15 10 6 12 4 6 6 2
2024/2025193 11 63 35 84 0 0 0 0 0 0 0 0
Totale 808